158 related articles for article (PubMed ID: 21928410)
1. Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome.
Ganly I; Bocker J; Carlson DL; D'Arpa S; Coleman M; Lee N; Pfister DG; Shah JP; Patel SG
Head Neck; 2011 Oct; 33(10):1387-93. PubMed ID: 21928410
[TBL] [Abstract][Full Text] [Related]
2. Predictors of outcome for advanced-stage supraglottic laryngeal cancer.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle J; Wong RJ; Lee N; Pfister DG; Shaha AR; Shah JP
Head Neck; 2009 Nov; 31(11):1489-95. PubMed ID: 19408292
[TBL] [Abstract][Full Text] [Related]
3. Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma.
Thariat J; Ang KK; Allen PK; Ahamad A; Williams MD; Myers JN; El-Naggar AK; Ginsberg LE; Rosenthal DI; Glisson BS; Morrison WH; Weber RS; Garden AS
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e367-74. PubMed ID: 22284033
[TBL] [Abstract][Full Text] [Related]
4. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
5. Concurrent chemoradiotherapy with capecitabine/cisplatin versus 5-fluorouracil/cisplatin in resectable laryngohypopharyngeal squamous cell carcinoma.
Ahn D; Sohn JH; Kim JH; Lee JE; Park SH; Kim JC
Ear Nose Throat J; 2016 Feb; 95(2):E34-42. PubMed ID: 26930342
[TBL] [Abstract][Full Text] [Related]
6. Regional control after concomitant chemoradiotherapy without planned neck dissection in node-positive head and neck squamous cell carcinomas.
Sakashita T; Homma A; Oridate N; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Auris Nasus Larynx; 2013 Apr; 40(2):211-5. PubMed ID: 22867524
[TBL] [Abstract][Full Text] [Related]
7. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.
Amsbaugh MJ; Yusuf M; Gaskins J; Silverman C; Potts K; Bumpous J; Redman R; Perez C; Dunlap N
Am J Otolaryngol; 2017; 38(5):588-592. PubMed ID: 28633765
[TBL] [Abstract][Full Text] [Related]
8. Planned neck dissection before combined chemoradiation in organ preservation protocol for N2-N3 of supraglottic or hypopharyngeal carcinoma.
Liu XK; Li Q; Zhang Q; Su Y; Shi YX; Li H; Zeng ZY; Guo ZM
ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):64-9. PubMed ID: 22327028
[TBL] [Abstract][Full Text] [Related]
9. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
Graboyes EM; Townsend ME; Kallogjeri D; Piccirillo JF; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1154-1163. PubMed ID: 27435696
[TBL] [Abstract][Full Text] [Related]
11. Should elective neck dissection be routinely performed in patients undergoing salvage total laryngectomy?
Pezier TF; Nixon IJ; Scotton W; Joshi A; Guerrero-Urbano T; Oakley R; Jeannon JP; Simo R
J Laryngol Otol; 2014 Mar; 128(3):279-83. PubMed ID: 24636080
[TBL] [Abstract][Full Text] [Related]
12. Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome.
Basheeth N; O'Leary G; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):790-6. PubMed ID: 23949354
[TBL] [Abstract][Full Text] [Related]
13. Neck recurrence in clinically node-negative oral cancer: 27-year experience at a single institution.
Mizrachi A; Migliacci JC; Montero PH; McBride S; Shah JP; Patel SG; Ganly I
Oral Oncol; 2018 Mar; 78():94-101. PubMed ID: 29496065
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell viability in salvage neck dissections: Poor prognosis predicted by high postradiation nodal SUV
Rüegg P; Morand GB; Kudura K; Rupp NJ; Hüllner MW; Broglie MA
Head Neck; 2020 Apr; 42(4):660-669. PubMed ID: 31854495
[TBL] [Abstract][Full Text] [Related]
15. [Chemoradiotherapy in the combined treatment for laryngopharyngeal cancer].
Choĭnzonov EL; Chizhevskaia SIu; Balatskaia LN
Vopr Onkol; 2014; 60(4):510-3. PubMed ID: 25552074
[TBL] [Abstract][Full Text] [Related]
16. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy for cancer of the laryngopharynx.
Goldman JL; Gunsberg MJ; Friedman WH; Ryan JR; Bloom BS
Arch Otolaryngol; 1970 Sep; 92(3):221-5. PubMed ID: 5502423
[No Abstract] [Full Text] [Related]
18. Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation.
van der Putten L; van den Broek GB; de Bree R; van den Brekel MW; Balm AJ; Hoebers FJ; Doornaert P; Leemans CR; Rasch CR
Head Neck; 2009 May; 31(5):593-603. PubMed ID: 19132716
[TBL] [Abstract][Full Text] [Related]
19. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
20. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
